George B. Mychaliska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George B. Mychaliska has a total of 447 co-authors. Here are the top co-authors by number of shared publications:
Ronald B. Hirschl
Section of Pediatric Surgery, Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI
17 shared publicationsMarjorie C. Treadwell
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Michigan, Michigan Medicine; Fetal Diagnosis and Treatment Center, University of Michigan, Michigan Medicine
14 shared publicationsJulia Wynn
Department of Pediatrics, Columbia University Medical Center, New York, NY, USA
11 shared publicationsRobert A. Drongowski
Section of Pediatric Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI
11 shared publicationsRobert H. Bartlett
Department of Surgery, ECLS Laboratory, University of Michigan Medical School, Ann Arbor, Michigan
11 shared publications- Gudrun Aspelund
Department of Surgery, Columbia University Medical Center, New York, NY, USA
10 shared publications
Latest Publications
- 2 September 2024
- Published by Elsevier in The Journal of Pediatrics
- Vol. 276, 114286
Patterns and Outcomes of Epoprostenol Use in Infants with Congenital Diaphragmatic Hernia Requiring Extracorporeal Life Support
- 2 September 2024
- Published by Elsevier in The Journal of Pediatrics
- Vol. 276, 114286
Patterns and Outcomes of Epoprostenol Use in Infants with Congenital Diaphragmatic Hernia Requiring Extracorporeal Life Support
- 22 March 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (2) , 460-465
The role of fetal hemoglobin in the artificial placenta: A premature ovine model
Introduction: A radical paradigm shift in the treatment of premature infants failing conventional treatment is to recreate fetal physiology using an extracorporeal Artificial Placenta (AP). The aim of this study is to evaluate the effects of changing fetal hemoglobin percent (HbF%) on physiology and circuit function during AP support in an ovine model. Methods: Extremely premature lambs ( n = 5) were delivered by cesarean section at 117-121 d estimated gestational age (EGA) (term = 145d), weighing 2.5 ± 0.35 kg. Lambs were cannulated using 10-14Fr cannulae for drainage via the right jugular vein and reinfusion via the umbilical vein. Lambs were intubated and lungs were filled with perfluorodecalin to a meniscus with a pressure of 5–8 cm H2O. The first option for transfusion was fetal whole blood from twins followed by maternal red blood cells. Arterial blood gases were used to titrate AP support to maintain fetal blood gas values. Results: The mean survival time on circuit was 119.6 ± 39.5 h. Hemodynamic parameters and lactate were stable throughout. As more adult blood transfusions were given to maintain hemoglobin at 10 mg/dL, the HbF% declined, reaching 40% by post operative day 7. The HbF% was inversely proportional to flow rates as higher flows were required to maintain adequate oxygen saturation and perfusion. Conclusions: Transfusion of adult blood led to decreased fetal hemoglobin concentration during AP support. The HbF% was inversely proportional to flow rates. Future directions include strategies to decrease the priming volume and establishing a fetal blood bank to have blood rich in HbF.
- 22 March 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (2) , 460-465
The role of fetal hemoglobin in the artificial placenta: A premature ovine model
Introduction: A radical paradigm shift in the treatment of premature infants failing conventional treatment is to recreate fetal physiology using an extracorporeal Artificial Placenta (AP). The aim of this study is to evaluate the effects of changing fetal hemoglobin percent (HbF%) on physiology and circuit function during AP support in an ovine model. Methods: Extremely premature lambs ( n = 5) were delivered by cesarean section at 117-121 d estimated gestational age (EGA) (term = 145d), weighing 2.5 ± 0.35 kg. Lambs were cannulated using 10-14Fr cannulae for drainage via the right jugular vein and reinfusion via the umbilical vein. Lambs were intubated and lungs were filled with perfluorodecalin to a meniscus with a pressure of 5–8 cm H2O. The first option for transfusion was fetal whole blood from twins followed by maternal red blood cells. Arterial blood gases were used to titrate AP support to maintain fetal blood gas values. Results: The mean survival time on circuit was 119.6 ± 39.5 h. Hemodynamic parameters and lactate were stable throughout. As more adult blood transfusions were given to maintain hemoglobin at 10 mg/dL, the HbF% declined, reaching 40% by post operative day 7. The HbF% was inversely proportional to flow rates as higher flows were required to maintain adequate oxygen saturation and perfusion. Conclusions: Transfusion of adult blood led to decreased fetal hemoglobin concentration during AP support. The HbF% was inversely proportional to flow rates. Future directions include strategies to decrease the priming volume and establishing a fetal blood bank to have blood rich in HbF.
- 17 October 2023
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 32 (4) , 151336
The new frontier in ECLS: Artificial placenta and artificial womb for premature infants
- 17 October 2023
- Published by Elsevier in Seminars in Pediatric Surgery
- Vol. 32 (4) , 151336
The new frontier in ECLS: Artificial placenta and artificial womb for premature infants
- 17 November 2022
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 27 (6) , 101408
Milestones for clinical translation of the artificial placenta
- 17 November 2022
- Published by Elsevier in Seminars in Fetal and Neonatal Medicine
- Vol. 27 (6) , 101408
Milestones for clinical translation of the artificial placenta
- 31 October 2022
- Published by Elsevier in Clinics in Perinatology
- Vol. 49 (4) , 873-891
Updates in Neonatal Extracorporeal Membrane Oxygenation and the Artificial Placenta
- 31 October 2022
- Published by Elsevier in Clinics in Perinatology
- Vol. 49 (4) , 873-891
Updates in Neonatal Extracorporeal Membrane Oxygenation and the Artificial Placenta
- Open Access
- 5 April 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (7) , 949-955
Hepatic Function in Premature Lambs Supported by the Artificial Placenta and Total Parenteral Nutrition
The artificial placenta (AP) promotes organ development and reduces organ injury in a lamb model of extreme prematurity. This study evaluates hepatic outcomes after AP support with total parenteral nutrition (TPN) administration. Premature lambs (116–121 days estimated gestational age; term = 145) were cannulated for 7 days of AP support. Lambs received TPN with SMOFlipid (n = 7) or Intralipid (n = 5). Liver function and injury were compared between the two groups biochemically and histologically. Groups were compared by ANOVA with Tukey’s multiple comparisons or linear-mixed effects models. From baseline to day 7, total bilirubin (Intralipid 2.6 ± 2.3 to 7.9 ± 4.4 mg/dl; SMOFlipid 0.3 ± 0.1 to 5.5 ± 2.3 mg/dl), alanine aminotransferase, and gamma-glutamyl transferase increased in both groups (p < 0.001 for all). Direct bilirubin (0.3 ± 0.2 to 1.8 ± 1.4 mg/dl; p = 0.006) and AST (27 ± 5 to 309 ± 242 mg/dl; p < 0.001) increased in SMOFlipid group (not measured in Intralipid group). On liver histology, Intralipid showed more cholestasis than SMOFlipid; both groups showed more than tissue controls. The Intralipid group alone showed hepatocyte injury and had more congestion than controls. Lambs supported by the AP with TPN administration maintain normal hepatic function and sustain minimal hepatic injury. SMOFlipid is associated with decreased cholestasis and hepatic injury versus Intralipid.
- 5 April 2022
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (7) , 949-955
Open AccessHepatic Function in Premature Lambs Supported by the Artificial Placenta and Total Parenteral Nutrition
The artificial placenta (AP) promotes organ development and reduces organ injury in a lamb model of extreme prematurity. This study evaluates hepatic outcomes after AP support with total parenteral nutrition (TPN) administration. Premature lambs (116–121 days estimated gestational age; term = 145) were cannulated for 7 days of AP support. Lambs received TPN with SMOFlipid (n = 7) or Intralipid (n = 5). Liver function and injury were compared between the two groups biochemically and histologically. Groups were compared by ANOVA with Tukey’s multiple comparisons or linear-mixed effects models. From baseline to day 7, total bilirubin (Intralipid 2.6 ± 2.3 to 7.9 ± 4.4 mg/dl; SMOFlipid 0.3 ± 0.1 to 5.5 ± 2.3 mg/dl), alanine aminotransferase, and gamma-glutamyl transferase increased in both groups (p < 0.001 for all). Direct bilirubin (0.3 ± 0.2 to 1.8 ± 1.4 mg/dl; p = 0.006) and AST (27 ± 5 to 309 ± 242 mg/dl; p < 0.001) increased in SMOFlipid group (not measured in Intralipid group). On liver histology, Intralipid showed more cholestasis than SMOFlipid; both groups showed more than tissue controls. The Intralipid group alone showed hepatocyte injury and had more congestion than controls. Lambs supported by the AP with TPN administration maintain normal hepatic function and sustain minimal hepatic injury. SMOFlipid is associated with decreased cholestasis and hepatic injury versus Intralipid.
- Open Access
- 1 May 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 10 (5) , 1399-1400
Fetal therapy: an eye towards the future
Fetal therapy: an eye towards the future
- 1 May 2021
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 10 (5) , 1399-1400
Open AccessFetal therapy: an eye towards the future
Fetal therapy: an eye towards the future
- 30 December 2020
- Published by Taylor & Francis
- p. 109-116
Congenital diaphragmatic hernia
Congenital diaphragmatic hernia (CDH) occurs in up to 1 in 2500 live births. It is a field defect, involving the lungs, foregut, and chest wall, resulting from failure of the diaphragm to separate the pleuroperitoneal canal into the thorax and abdomen before the midgut returns through the umbilicus. Consequently, the abdominal viscera translocate into the chest in the first trimester when the lungs are at a vulnerable lung bud or glandular stage ( Figure 13.1 ). The defect is typically located posteriolaterally, named Bochdalek hernia, and most of the chapter will focus on this type. Information specifically on Morgagni hernias which are anteriomedial defects is at the end of the chapter.
- 30 December 2020
- Published by Taylor & Francis
- p. 109-116
Congenital diaphragmatic hernia
Congenital diaphragmatic hernia (CDH) occurs in up to 1 in 2500 live births. It is a field defect, involving the lungs, foregut, and chest wall, resulting from failure of the diaphragm to separate the pleuroperitoneal canal into the thorax and abdomen before the midgut returns through the umbilicus. Consequently, the abdominal viscera translocate into the chest in the first trimester when the lungs are at a vulnerable lung bud or glandular stage ( Figure 13.1 ). The defect is typically located posteriolaterally, named Bochdalek hernia, and most of the chapter will focus on this type. Information specifically on Morgagni hernias which are anteriomedial defects is at the end of the chapter.
- 1 September 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (9) , 1879-1884
Discordant prenatal ultrasound and fetal MRI in CDH: wherein lies the truth?
- 1 September 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (9) , 1879-1884
Discordant prenatal ultrasound and fetal MRI in CDH: wherein lies the truth?
- 18 March 2020
- Published by Springer Nature in Journal of Perinatology
- Vol. 40 (5) , 695-703
Comparing mortality risk models in VLBW and preterm infants: systematic review and meta-analysis
Objective To compare the prognostic accuracy of six neonatal illness severity scores (CRIB, CRIB II, SNAP, SNAP II, SNAP-PE, and SNAP-PE II), birthweight (BW), and gestational age (GA) for predicting pre-discharge mortality among very low birth weight (VLBW) infants (<1500 g) and very preterm infants (<32 weeks’ gestational age). Study design PubMed, EMBASE, and Scopus were the data sources searched for studies published before January 2019. Data were extracted, pooled, and analyzed using random-effects models and reported as AUC with 95% confidence intervals (CI). Results Of 1659 screened studies, 24 met inclusion criteria. CRIB was the most discriminate for predicting pre-discharge mortality [AUC 0.88 (0.86–0.90)]. GA was the least discriminate [AUC 0.76 (0.72–0.80)]. Conclusions Although the original CRIB score was the most accurate predictor of pre-discharge mortality, significant heterogeneity between studies lowers confidence in this pooled estimate. A more precise illness severity score to predict pre-discharge mortality is still needed.
- 18 March 2020
- Published by Springer Nature in Journal of Perinatology
- Vol. 40 (5) , 695-703
Comparing mortality risk models in VLBW and preterm infants: systematic review and meta-analysis
Objective To compare the prognostic accuracy of six neonatal illness severity scores (CRIB, CRIB II, SNAP, SNAP II, SNAP-PE, and SNAP-PE II), birthweight (BW), and gestational age (GA) for predicting pre-discharge mortality among very low birth weight (VLBW) infants (<1500 g) and very preterm infants (<32 weeks’ gestational age). Study design PubMed, EMBASE, and Scopus were the data sources searched for studies published before January 2019. Data were extracted, pooled, and analyzed using random-effects models and reported as AUC with 95% confidence intervals (CI). Results Of 1659 screened studies, 24 met inclusion criteria. CRIB was the most discriminate for predicting pre-discharge mortality [AUC 0.88 (0.86–0.90)]. GA was the least discriminate [AUC 0.76 (0.72–0.80)]. Conclusions Although the original CRIB score was the most accurate predictor of pre-discharge mortality, significant heterogeneity between studies lowers confidence in this pooled estimate. A more precise illness severity score to predict pre-discharge mortality is still needed.